Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Zastrzyk życia
  • Obniżka
Patient Management with Stable Ischemic Heart Disease, An Issue of Medical Clinics of North America

Patient Management with Stable Ischemic Heart Disease, An Issue of Medical Clinics of North America

9780443293689
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
423,31 zł
359,81 zł Zniżka 63,50 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 359,81 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DHL, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
In this issue of Medical Clinics of North America, guest editors Drs. Alexander Fanaroff and John W. Hirschfeld, Jr., bring their considerable expertise to the topic of Patient Management with Stable Ischemic Heart Disease. Top experts provide insights into newer diagnostic modalities for patients presenting with symptoms of stable ischemic heart disease, review the pillars of medical management as well as emerging cardiometabolic therapies, provide updates on the role of revascularization, and reveal gender, racial, ethnic, and socioeconomic disparities in the presentation and management of stable ischemic heart disease.
Szczegóły produktu
Elsevier
100413
9780443293689
9780443293689

Opis

Rok wydania
2024
Numer wydania
1
Oprawa
twarda
Liczba stron
240
Wymiary (mm)
152 x 229
Waga (g)
450
  • The Pathophysiologic Basis of Managing Chronic Atherosclerotic Cardiovascular Disease
    Diagnosing Coronary Artery Disease in the Patient Presenting with Stable Ischemic Heart Disease: The Role of Anatomic versus Functional Testing
    Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024: Focus on Blood Pressure and Lipids
    Optimal Medical Therapy for Stable Ischemic Heart Disease: Focus on Anti-anginal Therapy
    A New Age for Secondary Prevention: Optimal Medical Therapy for Stable Ischemic Heart Disease Among Patients with Diabetes and/or Obesity
    Optimal Medical Therapy for Chronic Coronary Disease in 2024: Focus on Antithrombotic Therapy
    Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024: Focus on Exercise and Cardiac Rehabilitation
    When to Consider Coronary Revascularization for Stable Coronary Artery Disease
    Antiplatelet Therapy for Patients Who Have Undergone Revascularization Within the Past Year: Which Agents and for How Long?
    Medical Decision-Making and Revascularization in Ischemic Cardiomyopathy
    Ischemic Heart Disease in Women
    Chronic Coronary Disease in Older Adults
    Racial and Ethnic Disparities in the Management of Chronic Coronary Disease
Komentarze (0)
Ostatnio przeglądane

  • Często kupowane razem

    Brak dostępnych produktów